Selected publications:
George SL, Izquierdo E, Campbell J, Koutroumanidou E, Proszek P, Jamal S, Hughes D, Yuan L, Marshall LV, Carceller F, Chisholm JC, Vaidya S, Mandeville H, Angelini P, Wasti A, Bexelius T, Thway K, Gatz SA, Clarke M, Al-Lazikani B, Barone G, Anderson J, Tweddle DA, Gonzalez D, Walker BA, Barton J, Depani S, Eze J, Ahmed SW, Moreno L, Pearson A, Shipley J, Jones C, Hargrave D, Jacques TS, Hubank M, Chesler L. (2019) A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. Eur J Cancer. 121:224-235. doi: 10.1016/j.ejca.2019.07.027. Epub 2019 Sep 19.
Romo-Morales A, Aladowicz E, Blagg J, Gatz SA, Shipley JM. (2019) Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy. Pediatr Blood Cancer. 66(9):e27888. doi: 10.1002/pbc.27888. Epub 2019 Jun 17.
Izquierdo-Delgado E., Yuan, L., George, S., Hubank, M., Jones, C., Proszek, P. Shipley, J., Gatz, S.A., Stinson, C., Moore, A.S., Clifford, S.C., Hicks, D. Lindsey, J., Hill R., Jacques, T.S., Chalker, J., Thway, K., O’Connor, S., Marshall, L., Moreno, L., Pearson, A., Chesler, L., Walker, B.A. and Gonzales de Castro, D. (2017) Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours. Oncotarget, 8(67):112036-112050. doi: 10.18632/oncotarget.23000. eCollection 2017 Dec 19.
Gatz, S.A.*, Salles, D.*, Jacobsen, E.M., Dörk, T., Rausch, T., Aydin, S., Surowy, H., Volcic, M., Vogel, W., Debatin, K.M., Stütz, A.M., Schwarz, K., Pannicke, U., Hess, T., Korbel, J.O., Schulz, A.S., Schumacher, J. and Wiesmüller L. (2016) MCM3AP and POMP Mutations Cause a DNA-Repair and DNA-Damage-Signaling Defect in an Immunodeficient Child. Hum Mutat, 37(3), 257-68. doi: 10.1002/humu.22939. Epub 2015 Dec 30.
Gatz, S.A. and Shipley, J.M. (2015) Less Can Be More for Gene Dose and Drug Sensitivity. Commentary. Clin Cancer Res., 21(21), 4750-2. doi: 10.1158/1078-0432.CCR-15-1153. Epub 2015 Jul 21.Commentary
Norman, G., Fayter, D., Lewis-Light, K., Chisholm, J., McHugh, K., Levine, D., Jenney, M., Mandeville, H., Gatz, S. and Phillips, B. (2015) An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review. BMJ Open, 5(1):e006030. doi: 10.1136/bmjopen-2014-006030.
Morgenstern, D.A., Hargrave, D., Marshall, L.V., Gatz, S.A., Barone, G., Crowe, T., Pritchard-Jones, K., Zacharoulis, S., Lancaster, D.L., Vaidya, S.J., Chisholm, J.C., Pearson, A.D. and Moreno, L. (2014) Toxicity and Outcome of Children and Adolescents Participating in Phase I/II Trials of Novel Anticancer Drugs: The Royal Marsden Experience. J Pediatr Hematol Oncol, 36, 218-223. doi: 10.1097/MPH.0000000000000003.
Gatz, S.A., Ju, L., Gruber, R., Hoffmann, E., Carr, A.M., Wang, Z.Q., Liu, C. and Jeggo, P.A. (2011) Requirement for DNA Ligase IV during Embryonic Neuronal Development. J Neurosci, 31, 10088-10100. doi: 10.1523/JNEUROSCI.1324-11.2011. Erratum in: J Neurosci. 2011 Sep 21;31(38):13695.
Uhl, M., Csernok, A., Aydin, S., Kreienberg, R., Wiesmüller, L.* and Gatz, S.A.* (2010) Role of SIRT1 in Homologous Recombination. DNA Repair, 9, 383-393. doi: 10.1016/j.dnarep.2009.12.020. Epub 2010 Jan 25.
Gatz, S.A., Keimling, M., Baumann, C., Dörk, T., Debatin, K.-M., Fulda, S. and Wiesmüller, L. (2008) Resveratrol modulates DNA double-strand repair pathways in an ATM/ATR-p53- and –Nbs1-dependent manner. Carcinogenesis, 29, 519-527. doi: 10.1093/carcin/bgm283. Epub 2008 Jan 3.
Gatz, S.A., and Wiesmüller, L. (2008) Take a break - resveratrol in action on DNA. Carcinogenesis, 29, 321-332. oi: 10.1093/carcin/bgm276. Epub 2008 Jan 3. Review
Gatz, S.A., and Wiesmüller, L. (2006) p53 in recombination and repair. Cell Death Differ., 13, 1003-1016. Review
Gatz SA, Pohla H, Schendel DJ. A PCR-SSP method to specifically select HLA-A*0201 individuals for immunotherapeutic studies. Tissue Antigens. 2000 Jun;55(6):532-47.
View all publications in research portal